NCT06744504
- Conditions
- AML, RUNX1-RUNX1T1 Fusion Protein Expression
- Locations
-
- Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
RUNX1-RUNX1T1 Fusion Protein Expression
Explore clinical trials studying RUNX1-RUNX1T1 Fusion Protein Expression. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study